(Stroke. 2002;33:462.)
© 2002 American Heart Association, Inc.
Original Contributions |
Department of Epidemiology & Biostatistics (R.V., M.H., M.M.B.B., D.A.M. van der K., A.H., J.C.M.W.) and Department of Radiology, Daniel den Hoed Clinic (M.O.), Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands, and Department of Radiology, State University Groningen/Academic Hospital Groningen, Groningen, The Netherlands (M.O., R.V.).
Reprint requests to J.C.M. Witteman, PhD, Department of Epidemiology & Biostatistics, Erasmus Medical Center Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, the Netherlands. E-mail witteman{at}epib.fgg.eur.nl
| Abstract |
|---|
|
|
|---|
Methods From 1997 onward, subjects were invited to participate in the prospective Rotterdam Coronary Calcification Study and undergo electron-beam CT to detect coronary calcification. The study was embedded in the population-based Rotterdam Study. Calcifications were quantified in a calcium score according to Agatstons method. Calcium scores were available for 2013 subjects (mean age [SD], 71 [5.7] years). Fifty subjects had experienced stroke before scanning.
Results Subjects were 2 times more likely to have experienced stroke when their calcium score was between 101 and 500 (odds ratio [OR], 2.1; 95% CI, 0.9 to 4.7) and 3 times more likely when their calcium score was above 500 (OR, 3.3; 95% CI, 1.5 to 7.2), compared with subjects in the lowest calcium score category (0 to 100). Additional adjustment for cardiovascular risk factors did not materially alter the risk estimates.
Conclusions In this population-based study, a markedly graded association was found between coronary calcification and stroke. The results suggest that coronary calcification as detected by electron-beam CT may be useful to identify subjects at high risk of stroke.
Key Words: atherosclerosis calcium epidemiology stroke tomography
| Introduction |
|---|
|
|
|---|
| Subjects and Methods |
|---|
|
|
|---|
From 1997 onward, participants through 85 years of age who completed the third phase of the first cohort or the baseline examination of the second cohort of the Rotterdam Study were invited to participate in the Rotterdam Coronary Calcification Study and undergo an electron-beam CT scan. Subjects in nursing homes did not visit the research center and thus were not invited to join the Rotterdam Coronary Calcification Study. We restricted the present analysis to participants from the first cohort, who were scanned from 19972000. Of the 3371 eligible participants recruited from the first cohort, scans were obtained for 2063 subjects (response 61%). As a result of several causes, ie, metal clips from cardiac surgery, severe artifacts, and registration errors (ECG, acquisition), image acquisition data could not be reconstructed or analyzed in 50 subjects. Consequently, scores were available for 2013 participants. All other measurements were obtained from the examinations of the Rotterdam Study. The median duration between the examination at the Rotterdam Study center and electron-beam CT scanning was 50 days. The Medical Ethics Committee of Erasmus University Rotterdam approved the study, and all participants gave informed consent.
Measurement of Coronary Calcifications
We assessed coronary calcifications in the epicardial coronary arteries detected on electron-beam CT scans. Imaging was performed with a C-150 Imatron scanner (Imatron). Before the subjects were scanned, they exercised adequate breath-holding. From the level of the root of the aorta through the heart, 38 images were obtained with 100-ms scan time and 3-mm slice thickness. We acquired images at 80% of the cardiac cycle, using ECG triggering, during a single breath-hold. Every day that the scanner was used, we calibrated the scanner using a water phantom. Quantification of coronary calcifications was performed with AccuImage software (AccuImage Diagnostics Corporation) displaying all pixels with a density of over 130 Hounsfield units. The trained scan readers were blinded to the clinical data of the participants. A calcification was defined as a minimum of two adjacent pixels (area=0.65 mm2) with a density over 130 Hounsfield units. We placed a region of interest around each high-density lesion in the epicardial coronary arteries. The peak density in Hounsfield units and the area in mm2 of the individual coronary calcifications were calculated. A calcium score was obtained by multiplying each area of interest with a factor indicating peak density within the individual area, as proposed by Agatston et al.16 We summated the scores for individual calcifications, which resulted in a calcium score for the entire epicardial coronary system. To conform with the protocol outlines as approved by the Medical Ethics Committee, participants were not informed about their calcium score.
Diagnosis of Stroke
A stroke was categorized as present if stroke had occurred before the baseline examination from 19901993 or after baseline but before electron-beam CT scanning (19972000). Of subjects who reported a history of stroke at the baseline examination, the general practitioner (GP) was asked for supplementary medical information, including a detailed history, information on neuroimaging, and copies of hospital discharge records. After the baseline examination, GPs in the research area, covering 85% of the cohort, reported the possible stroke events to the research center. For 15% of the cohort, of which the GPs had practices outside the research area, information was obtained annually by checking the participants GP file and by interviewing the GP. When an event was reported, additional information including the date of the possible stroke was obtained by interviewing the GP and scrutinizing information from hospital discharge records and/or neuroimaging in the case of admission or referral. Medical information was checked and evaluated by an experienced neurologist from the Erasmus Medical Center Rotterdam. Events were coded according to the International Classification of Diseases, 10th version.17 The neurologist classified the events as definite, probable, possible, and no stroke. A stroke was classified by the neurologist as definite when the event led to a hospitalization, and the hospital discharge record indicated a diagnosis of a new stroke, based on clinical signs and symptoms and/or on neuroimaging during hospital stay. When, in the case of no hospitalization, signs and symptoms associated with the event obtained from the GP records and interview were highly suggestive of a stroke according to the neurologist, the stroke was classified as probable. Definite and probable events were used in the analyses.
Measurement of Cardiovascular Risk Factors
Information on smoking was obtained during the home interview of the Rotterdam Study. We categorized subjects as current, past, or never smokers. Anthropometric measures were obtained during the visit at the Rotterdam research center. Blood pressure was measured at the right brachial artery using a random-zero sphygmomanometer with the participant in sitting position. The mean value of two consecutive measurements was used in the analyses. Hypertension was defined as a systolic blood pressure of 140 mm Hg or higher or a diastolic blood pressure of 90 mm Hg or higher. After an overnight of fasting, blood samples were obtained at the research center. Serum total cholesterol was determined by an enzymatic procedure. High-density lipoprotein (HDL) was measured similarly after precipitation of the non-HDL fraction.18 Diabetes mellitus was considered present with current use of antidiabetic medication or when fasting glucose levels exceeded 7.0 mmol/L.19
Statistical Analysis
The distribution of calcium scores was skewed, and therefore, medians and ranges were reported. Linear regression analysis was applied to compare the age-adjusted continuous baseline characteristics of the Rotterdam Coronary Calcification Study and the nonresponders. To compare sex, smoking status, and the percentage of subjects with hypertension, diabetes mellitus, stroke, and myocardial infarction between the study population and the group of nonresponders, the chi-square test was used. Three absolute calcium score categories were defined, based on cut points that were chosen before examining the association with the presence of stroke: 0 to 100, 101 to 500, and above 500. Age- and sex-adjusted odds ratios (OR) with 95% CI for the presence of stroke were calculated per calcium score category using logistic regression analysis. Calcium score category 0 to 100 was used as reference. Analyses for calcium score categories were repeated with additional adjustment for cardiovascular risk factors (smoking, total cholesterol, HDL cholesterol, hypertension, diabetes mellitus). Age-adjusted ORs (95% CI) were also calculated for men and women separately. SPSS 9.0 for Windows, (SPSS Inc) was used for data analysis.
| Results |
|---|
|
|
|---|
|
In logistic regression analysis, a graded association was found between the amount of coronary calcification and the presence of stroke (Table 2). The age-adjusted OR of stroke were 2.1 (95% CI, 0.9 to 4.7) in calcium score category 101 to 500, and 3.3 (95% CI, 1.5 to 7.2) in subjects with a calcium score above 500, when compared with subjects in the reference category (calcium score of 0 to 100). Additional adjustment for cardiovascular risk factors did not substantially alter the results (model 2).
|
Table 3 shows risk estimates for men and women separately. In men, age-adjusted OR for the presence of stroke increased from 3.5 (95% CI, 0.9 to 12.8) in calcium score category 101 to 500, to 5.2 (95% CI, 1.5 to 17.8) in calcium score category above 500, when compared with subjects in the reference category (calcium score of 0 to 100). The corresponding age-adjusted OR in women were 1.3 (95% CI, 0.4 to 4.6) and 2.4 (95% CI, 0.7 to 7.8), respectively. In men, 62% of the strokes occurred in the calcium score category above 500, whereas in women this percentage was 31.
|
| Discussion |
|---|
|
|
|---|
Scans were obtained from 2063 subjects recruited from the first cohort of the Rotterdam Study. Comparison of all characteristics of the participants of the Rotterdam Coronary Calcification Study with the nonresponders showed a relevant difference only in the mean age, the percentage of men, and the percentage of subjects with a history of smoking. Subjects with severe disability, possibly resulting from stroke, may not have shown up for electron-beam CT scanning. If reasons for nonparticipation are related to the amount of coronary calcification, this may have limited the range of calcium scores in this study, because the highest calcium scores are to be expected in the subjects with disabling cardiovascular disease. Thus, we were not able to assess the possibly stronger association between coronary calcification and stroke in subjects with severe cardiovascular disease. Secondly, because of small numbers of cases, the confidence intervals of the sex-specific OR are wide. This should induce caution when drawing conclusions on the strength of the association in men and women. To obtain more reliable risk estimates on the association between coronary calcification and stroke by gender, more cases are needed. Furthermore, the threshold used in this study for detection of coronary calcifications was 2 consecutive pixels. Some studies have used higher thresholds to reduce the contribution of noise. However, in a subgroup of subjects, we found a very high correlation coefficient (r=0.99) between calcium scores obtained using a threshold of 2 pixels and a threshold of 4 pixels. Thirdly, because of the fact that the association of coronary calcification with stroke was evaluated in a cross-sectional study design, only survivors of a cerebrovascular event were included. It is uncertain whether the same risk estimates would have been found for fatal events. Moreover, survivors of stroke are more likely to have had less severe types of stroke, such as lacunar infarctions, possibly limiting the range of stroke severity. Because there was an interval between the occurrence of stroke and scanning of 8.8 years on average, subjects may have been classified into a different calcium score category than the classification would have been if coronary calcification had been measured at the time of the cerebrovascular event. Furthermore, the cerebrovascular event in the past may have initiated medication use to reduce cardiovascular risk. This could have diminished the difference in coronary calcium load between subjects with and without stroke, resulting in underestimation of the OR. After adjustment for cardiovascular determinants, risk estimates changed only slightly. This lack of change may in part be a result of modification of risk factors in subjects after the cerebrovascular event, leading to misclassification of risk factors.
Noninvasive measures of atherosclerosis have been shown to predict cerebrovascular events. Studies investigating the relation of carotid intima-media thickness with stroke have presented relative risks ranging between 3.4 and 8.5 for highest versus lowest quintile or category of intima-media thickness.1 Low ankle brachial pressure index also indicates an increased risk of stroke, but relative risks of stroke associated with this measure were lower.4 Because we investigated the association between coronary calcification and stroke in a cross-sectional design, the risk estimates cannot be compared directly with the results from these prospective studies. However, in our study, coronary calcification was strongly related to the presence of stroke. Therefore, coronary calcium detection by electron-beam CT may not only be useful to identify subjects at high risk of coronary heart disease but additionally those at high risk of stroke.
Conclusion
In conclusion, we observed a markedly graded association between the amount of coronary calcification and stroke in an elderly population. This is the first study on the association between coronary calcification as detected by electron-beam CT and stroke. Although prospective data need to confirm our findings, this population-based cross-sectional study suggests that the amount of coronary calcification identifies subjects at high risk of cerebrovascular events.
| Acknowledgments |
|---|
Received June 25, 2001; revision received September 28, 2001; accepted November 15, 2001.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. Y. Alexander, F. L. Wilkinson, J. P. Kirton, C. F. Rock, G. D.M. Collett, M. Jeziorska, J. V. Smyth, A. M. Heagerty, and A. E. Canfield Identification and Characterization of Vascular Calcification-Associated Factor, a Novel Gene Upregulated During Vascular Calcification In Vitro and In Vivo Arterioscler. Thromb. Vasc. Biol., September 1, 2005; 25(9): 1851 - 1857. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Babiarz, D. M. Yousem, W. Bilker, and B. A. Wasserman Middle Cerebral Artery Infarction: Relationship of Cavernous Carotid Artery Calcification AJNR Am. J. Neuroradiol., June 1, 2005; 26(6): 1505 - 1511. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Giachelli, M. Y. Speer, X. Li, R. M. Rajachar, and H. Yang Regulation of Vascular Calcification: Roles of Phosphate and Osteopontin Circ. Res., April 15, 2005; 96(7): 717 - 722. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Vliegenthart, H.-H. S. Oei, A. P. M. van den Elzen, F. J. A. van Rooij, A. Hofman, M. Oudkerk, and J. C. M. Witteman Alcohol Consumption and Coronary Calcification in a General Population Arch Intern Med, November 22, 2004; 164(21): 2355 - 2360. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tiemeier, W. van Dijck, A. Hofman, J. C. M. Witteman, T. Stijnen, and M. M. B. Breteler Relationship Between Atherosclerosis and Late-Life Depression: The Rotterdam Study Arch Gen Psychiatry, April 1, 2004; 61(4): 369 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hollander, A.E. Hak, P.J. Koudstaal, M.L. Bots, D.E. Grobbee, A. Hofman, J.C.M. Witteman, and M.M.B. Breteler Comparison Between Measures of Atherosclerosis and Risk of Stroke: The Rotterdam Study Stroke, October 1, 2003; 34(10): 2367 - 2372. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ikeda, H. Ohno, M. Tamura, H. Kashihara, K. Anan, K.-i. Hosozawa, M. Kinoshita, Y. Iwasaki, R. Vliegenthart, and J. C.M. Witteman Cerebral Atherosclerosis and Coronary Calcification Stroke, October 1, 2002; 33(10): 2345 - 2346. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |